A detailed history of Mutual Of America Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 261,885 shares of BMY stock, worth $14.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
261,885
Previous 271,597 3.58%
Holding current value
$14.2 Million
Previous $11.3 Million 20.15%
% of portfolio
0.15%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $385,177 - $502,596
-9,712 Reduced 3.58%
261,885 $13.6 Million
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $490,808 - $646,160
-12,194 Reduced 4.3%
271,597 $11.3 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $122,301 - $138,665
-2,549 Reduced 0.89%
283,791 $15.4 Million
Q4 2023

Jan 26, 2024

SELL
$48.48 - $57.85 $1.02 Million - $1.21 Million
-20,958 Reduced 6.82%
286,340 $14.7 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $602,229 - $673,386
-10,403 Reduced 3.27%
307,298 $17.8 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $156,216 - $173,454
-2,452 Reduced 0.77%
317,701 $20.3 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $722 - $819
-11 Reduced -0.0%
320,153 $22.2 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $497,918 - $589,605
7,271 Added 2.32%
320,164 $23 Million
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $682 - $403,563
5,252 Added 1.71%
312,893 $22.2 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $185,979 - $204,828
2,561 Added 0.84%
307,641 $23.7 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $135,440 - $162,405
-2,203 Reduced 0.72%
305,080 $22.3 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $32,392 - $37,762
604 Added 0.2%
307,283 $19.2 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $4,615 - $5,406
78 Added 0.03%
306,679 $18.1 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $87,726 - $95,534
1,417 Added 0.46%
306,601 $20.5 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $72,988 - $82,090
-1,230 Reduced 0.4%
305,184 $19.3 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $246,261 - $279,058
-4,265 Reduced 1.37%
306,414 $19 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $1.03 Million - $1.14 Million
-17,908 Reduced 5.45%
310,679 $18.7 Million
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $2.63 Million - $3.08 Million
-48,041 Reduced 12.76%
328,587 $19.3 Million
Q1 2020

May 11, 2020

BUY
$46.4 - $67.43 $92,660 - $134,657
1,997 Added 0.53%
376,628 $21 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $6.45 Million - $8.42 Million
131,118 Added 53.84%
374,631 $24 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $1.63 Million - $1.93 Million
-37,997 Reduced 13.5%
243,513 $12.3 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $144,122 - $159,368
3,230 Added 1.16%
281,510 $12.8 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $2.87 Million - $3.43 Million
63,707 Added 29.69%
278,280 $13.3 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $192,992 - $250,264
3,958 Added 1.88%
214,573 $11.2 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $13,521 - $15,251
-245 Reduced 0.12%
210,615 $13.1 Million
Q2 2018

Aug 09, 2018

SELL
$50.53 - $62.98 $3.29 Million - $4.1 Million
-65,139 Reduced 23.6%
210,860 $11.7 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $106,957 - $123,129
1,785 Added 0.65%
275,999 $17.5 Million
Q4 2017

Jan 31, 2018

BUY
$59.94 - $65.35 $681,877 - $743,421
11,376 Added 4.33%
274,214 $16.8 Million
Q3 2017

Oct 18, 2017

BUY
$55.23 - $63.74 $14.5 Million - $16.8 Million
262,838
262,838 $16.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.